Súlyos vérzés sikeres kezelése thrombocyta-suspensio és cryoprecipitatum együttes alkalmazásával III. típusú Willebrand-betegségben.

Z. Boda, G. Pfliegler, J. Hársfalvi, K. Rák

Research output: Review article

Abstract

A 24-year-old woman with severe haemorrhagic complication due to type III von Willebrand's disease is reported, as the first such case in Hungary. Analysis of seven family members affected by the type III mutant gene was compatible with an autosomal recessive mode of inheritance. Severe, iatrogenic epistaxis of the patient was not improved by cryoprecipitate and DDAVP. Platelet suspension together with cryoprecipitate immediately stopped bleeding. Simultaneous application of cellulare (platelet suspension) and plasmatic (cryoprecipitate) Willebrand protein is suggested for patients with severe (type III) von Willebrand's disease.

Translated title of the contributionSuccessful treatment of severe hemorrhage by using thrombocyte suspension with cryoprecipitate in type III Willebrand disease
Original languageHungarian
Pages (from-to)2499-2502
Number of pages4
JournalOrvosi hetilap
Volume132
Issue number45
Publication statusPublished - nov. 10 1991

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Súlyos vérzés sikeres kezelése thrombocyta-suspensio és cryoprecipitatum együttes alkalmazásával III. típusú Willebrand-betegségben.'. Together they form a unique fingerprint.

  • Cite this